PHASE I STUDY OF CHIMERIC ANTIGEN RECEPTOR-ENGINEERED T CELLS TARGETING IL13Rα2 FOR THE TREATMENT OF GLIOBLASTOMA

被引：0

作者：

Brown, Christine ^{[1
]}

Alizadeh, Darya ^{[2
]}

Starr, Renate ^{[2
]}

Weng, Lihong ^{[2
]}

Wagner, Jamie ^{[2
]}

Naranjo, Araceli ^{[2
]}

Blanchard, Suzette ^{[2
]}

Kilpatrick, Julie ^{[2
]}

Simpson, Jennifer ^{[2
]}

Ressler, Julie Ann ^{[2
]}

Jensen, Michael ^{[3
]}

Portnow, Jana ^{[2
]}

D'Apuzzo, Massimo ^{[2
]}

Barish, Michael ^{[4
]}

Forman, Stephen ^{[2
]}

Badie, Behnam ^{[5
]}

机构：

[1] City Hope Natl Med Ctr, Med Ctr, Dept Hematol HCT, Duarte, CA USA

[2] City Hope Comprehens Canc Ctr, Duarte, CA USA

[3] Seattle Childrens Res Inst, Seattle, WA USA

[4] City Hope Natl Med Ctr, Beckman Res Inst, Dept Devl Stem Cell Biol, Duarte, CA USA

[5] City Hope Comprehens Canc Ctr, Dept Neurosurg, Duarte, CA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ATIM-13

引用

页码：20 / 20

页数：1